Features and Management of Acute and Chronic Neuro-Covid 2021
DOI: 10.1007/978-3-030-86705-8_1
|View full text |Cite
|
Sign up to set email alerts
|

Pathophysiology of COVID-19-Associated Neurotoxicity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
167
0
6

Year Published

2022
2022
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 131 publications
(176 citation statements)
references
References 129 publications
3
167
0
6
Order By: Relevance
“…It has been noted that a low value of lymphocytes is an important indicator for the severity of a patient where lymphocytes are responsible for preserving immune homeostasis and the response of inflammatory cells; this may expose the patient to death [1,14,25,61]. The opposite is true for neutrophils, where a high value of this test reflects the severity of the illness; this is consistent with the findings of the machine-learning models in [1,34].…”
Section: E a R L Y B I R Dsupporting
confidence: 78%
“…It has been noted that a low value of lymphocytes is an important indicator for the severity of a patient where lymphocytes are responsible for preserving immune homeostasis and the response of inflammatory cells; this may expose the patient to death [1,14,25,61]. The opposite is true for neutrophils, where a high value of this test reflects the severity of the illness; this is consistent with the findings of the machine-learning models in [1,34].…”
Section: E a R L Y B I R Dsupporting
confidence: 78%
“…The human to human transfer is confirmed based on world wide data but the intermediate host is still unknown [1]. The first case report in Huanan Seafood Wholesale market of Wuhan suggested that initially SARS-CoV-2 showed animal-to-human transmission but subsequent cases confirmed about human-to-human transmission [2].…”
Section: Introductionmentioning
confidence: 93%
“…Virions are released afterwards [15]. Accumulative evidences suggest that the incubation time could be generally within 3e7 days and extend up to 2 weeks [2]. The characteristic clinical symptoms for the COVID-19 affected patients are high fever, dry cough, dyspnoea, lethal pneumonia whereas some patients show some additional neurological signs such as headache, disturbed consciousness and also acute cerebrovascular disease-related symptoms and neuromuscular symptoms [3,16].…”
Section: Initial Attachment Entry and Clinical Features Of Sars-cov2mentioning
confidence: 99%
“…Critical illness that culminates during the course of COVID-19 infection (acute respiratory distress syndrome, pneumonia, septic shock, multiorgan failure, opportunistic secondary infections, etc.) bears a striking semblance to the conditions that similarly admit non-COVID-19 patients to the ICU ( 14 ). Knowing these historical outcomes in critically ill patients, it is important to consider that even when this current pandemic does end, long-term patient sequelae will continue to be seen and need to be treated for years to come.…”
Section: Critical Illness and Known Long-term Outcomes From Previous ...mentioning
confidence: 99%